Logo 1 Logo 2

Clinical Trial Details

Trial ID: L0022
Source ID: NCT06752577
Associated Drug: Allogeneic, Vertebral Bone Marrow-Derived Mesenchymal Stem Cells (Msc)
Title: Safety and Tolerability of Vertebral Bone Marrow-derived Mesenchymal Stem Cells (BM-MSC) in Real World Scenarios of Patients with Chronic Kidney Disease (CKD)
Acronym:
Status: RECRUITING
Study Results: NO
Results:
Conditions: Chronic Kidney Diseases
Interventions: DRUG: Allogeneic, vertebral bone marrow-derived mesenchymal stem cells (MSC)
Outcome Measures: Primary: Adverse events and/or serious adverse events, Number of adverse events and/or serious adverse events associated with mesenchymal stem cells intervention, 6 months |
Sponsor/Collaborators: Sponsor: Mayo Clinic | Collaborators: Ossium Health, Inc.
Gender: ALL
Age: ADULT, OLDER_ADULT
Phases:
Enrollment: 50
Study Type: OBSERVATIONAL
Study Designs: Observational Model: |Time Perspective: p
Start Date: 2024-12-22
Completion Date: 2031-12-31
Results First Posted:
Last Update Posted: 2024-12-30
Locations: Mayo Clinic, Jacksonville, Florida, 32224, United States
URL: https://clinicaltrials.gov/show/NCT06752577